Published in Pediatrics on July 01, 2009
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med (2013) 6.60
Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med (2011) 2.59
New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J (2010) 2.53
A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis (2010) 2.23
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health (2014) 1.94
Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis (2011) 1.75
Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics (2010) 1.72
Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes. PLoS Genet (2014) 1.56
Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol (2010) 1.54
Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis (2011) 1.51
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis (2010) 1.41
Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J (2012) 1.41
Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio (2013) 1.40
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine (2010) 1.37
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev (2012) 1.31
Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J (2011) 1.28
Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts. J Pediatric Infect Dis Soc (2013) 1.27
Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One (2011) 1.25
Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol (2012) 1.24
Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine (2011) 1.22
Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized. J Korean Med Sci (2011) 1.13
Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine (2010) 1.12
Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis (2009) 1.11
Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology (2011) 1.09
Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol (2013) 1.09
Sequential multiplex PCR assay for determining capsular serotypes of colonizing S. pneumoniae. BMC Infect Dis (2011) 1.06
Elucidation of structural and antigenic properties of pneumococcal serotype 11A, 11B, 11C, and 11F polysaccharide capsules. J Bacteriol (2011) 1.05
Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine. J Korean Med Sci (2012) 1.04
Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate. BMC Microbiol (2011) 1.03
Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution. Clin Infect Dis (2012) 1.01
Streptococcus pneumoniae serotype 15A in psychiatric unit, Rhode Island, USA, 2010-2011. Emerg Infect Dis (2012) 0.98
Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol (2014) 0.98
Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy. PLoS One (2013) 0.97
Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Front Cell Infect Microbiol (2015) 0.97
A decade-long surveillance of nasopharyngeal colonisation with Streptococcus pneumoniae among children attending day-care centres in south-eastern France: 1999-2008. Eur J Clin Microbiol Infect Dis (2011) 0.97
Streptococcus pneumoniae serotype 9A isolates contain diverse mutations to wcjE that result in variable expression of serotype 9V-specific epitope. J Infect Dis (2011) 0.97
Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol Mol Biol Rev (2015) 0.95
Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland. BMC Infect Dis (2013) 0.93
Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci. Philos Trans R Soc Lond B Biol Sci (2015) 0.93
The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition. Microbiome (2014) 0.91
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial. PLoS One (2012) 0.91
Trends in antibiotic use in Massachusetts children, 2000-2009. Pediatrics (2012) 0.91
Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol (2014) 0.90
Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance. PLoS One (2013) 0.90
Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Infect Immun (2014) 0.90
The two variants of the Streptococcus pneumoniae pilus 1 RrgA adhesin retain the same function and elicit cross-protection in vivo. Infect Immun (2010) 0.90
Probing ligand-binding pockets of the mevalonate pathway enzymes from Streptococcus pneumoniae. J Biol Chem (2010) 0.90
Severe viral respiratory infections: are bugs bugging? Mucosal Immunol (2013) 0.90
Selective and genetic constraints on pneumococcal serotype switching. PLoS Genet (2015) 0.90
Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother (2013) 0.89
Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J (2014) 0.89
Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol (2010) 0.88
Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. Clin Vaccine Immunol (2010) 0.87
Streptococcus pneumoniae carriage in the Gaza strip. PLoS One (2012) 0.87
Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One (2014) 0.86
Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics (2013) 0.85
Heterotaxy syndrome: defining contemporary disease trends. Pediatr Cardiol (2010) 0.85
Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae. Bioorg Med Chem (2009) 0.84
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine. Vaccine (2012) 0.84
A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era. Hum Vaccin Immunother (2015) 0.84
Panel 6: Vaccines. Otolaryngol Head Neck Surg (2013) 0.83
Difference in Resistance to Streptococcus pneumoniae Infection in Mice. Lab Anim Res (2011) 0.83
Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France. BMC Infect Dis (2012) 0.83
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada. BMC Infect Dis (2012) 0.82
Enhanced detection and serotyping of Streptococcus pneumoniae using multiplex polymerase chain reaction. Korean J Pediatr (2012) 0.82
A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr (2011) 0.82
Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement. PLoS Comput Biol (2014) 0.82
Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media. Microbes Infect (2012) 0.81
Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study. BMC Infect Dis (2012) 0.81
Regulation of bacterial trafficking in the nasopharynx. Paediatr Respir Rev (2012) 0.81
Unveiling the burden of influenza-associated pneumococcal pneumonia. J Infect Dis (2011) 0.81
Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries. Infect Dis Obstet Gynecol (2011) 0.81
The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination. Proc Biol Sci (2013) 0.81
Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010. BMC Infect Dis (2012) 0.80
Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage. J Infect Dis (2015) 0.80
Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine. Vaccine (2010) 0.80
Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010. Pediatr Infect Dis J (2015) 0.80
Do community-level predictors of pneumococcal carriage continue to play a role in the conjugate vaccine era? Epidemiol Infect (2013) 0.80
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine. Medicine (Baltimore) (2015) 0.80
Climate induces seasonality in pneumococcal transmission. Sci Rep (2015) 0.79
Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced. BMC Infect Dis (2015) 0.79
Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae. Sci Data (2015) 0.79
Bacterial load of pneumococcal serotypes correlates with their prevalence and multiple serotypes is associated with acute respiratory infections among children less than 5 years of age. PLoS One (2014) 0.79
Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies. Epidemiol Infect (2012) 0.78
Nasopharyngeal Carriage Rate and Serotypes of Streptococcus pneumoniae and Antimicrobial Susceptibility in Healthy Korean Children Younger than 5 Years Old: Focus on Influence of Pneumococcal Conjugate Vaccination. Infect Chemother (2013) 0.78
Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine. PLoS One (2013) 0.78
The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease. PLoS Comput Biol (2015) 0.77
Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr (2013) 0.77
Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era. PLoS One (2016) 0.77
Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening. Proc Natl Acad Sci U S A (2017) 0.76
Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage. Proc Natl Acad Sci U S A (2017) 0.75
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians. Pediatr Infect Dis J (2016) 0.75
The changing epidemiology of childhood pneumococcal disease in Korea. Infect Chemother (2013) 0.75
Diagnostic usefulness of ribosomal protein l7/l12 for pneumococcal pneumonia in a mouse model. J Clin Microbiol (2012) 0.75
Antimicrobial susceptibility trends among Streptococcus pneumoniae over an 11-year period in an Iranian referral children Hospital. Iran J Microbiol (2014) 0.75
A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States. Hum Vaccin Immunother (2015) 0.75
Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine. J Korean Med Sci (2017) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29
Trends in antimicrobial prescribing rates for children and adolescents. JAMA (2002) 4.60
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep (2005) 4.39
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis (2005) 4.16
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis (2005) 3.76
Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis (1999) 3.72
Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA (2007) 3.69
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog (2007) 3.65
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics (2005) 3.42
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis (2008) 3.17
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep (2008) 3.03
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis (1996) 2.96
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93
Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis (2008) 2.72
The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol (2004) 2.70
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis (2009) 2.36
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis (2004) 2.08
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis (2006) 1.99
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J (2004) 1.96
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J (2004) 1.90
Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. MMWR Morb Mortal Wkly Rep (2007) 1.79
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med (2002) 1.66
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics (2008) 1.55
Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis (2005) 1.54
Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J (2003) 1.51
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol (2008) 1.45
Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J (2005) 1.39
Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics (2003) 1.37
Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J (2007) 1.09
Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm. Pediatr Infect Dis J (2006) 1.09
Does it really take longer not to prescribe antibiotics for viral respiratory tract infections in children? Ambul Pediatr (2006) 1.07
Replacement pneumococcal disease in perspective. Clin Infect Dis (2008) 0.87
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol (2004) 17.92
Transmissibility of 1918 pandemic influenza. Nature (2004) 16.14
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis (2008) 7.76
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19
Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci U S A (2007) 5.90
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis (2009) 5.56
Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol (2010) 5.43
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Maternal age and other predictors of newborn blood pressure. J Pediatr (2004) 4.78
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A (2003) 4.56
Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet (2011) 4.19
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05
Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99
Recombination and the nature of bacterial speciation. Science (2007) 3.98
Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr (2007) 3.89
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerg Infect Dis (2002) 3.79
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A (2004) 3.46
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics (2005) 3.42
Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A (2012) 3.42
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A (2005) 3.30
Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A (2007) 3.29
Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29
Weather-based prediction of Plasmodium falciparum malaria in epidemic-prone regions of Ethiopia I. Patterns of lagged weather effects reflect biological mechanisms. Malar J (2004) 3.07
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis (2002) 2.99
Timing of solid food introduction and risk of obesity in preschool-aged children. Pediatrics (2011) 2.99
Predictors of change in physical activity during and after pregnancy: Project Viva. Am J Prev Med (2007) 2.98
Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter? Diabetes Care (2006) 2.93
Maternal gestational weight gain and offspring weight in adolescence. Obstet Gynecol (2008) 2.90
Pandemic flu: we are not prepared. MedGenMed (2005) 2.89
The bacterial species challenge: making sense of genetic and ecological diversity. Science (2009) 2.88
Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol (2006) 2.81
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet (2013) 2.80
Racial/ethnic differences in early-life risk factors for childhood obesity. Pediatrics (2010) 2.73
Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis (2008) 2.70
Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog (2009) 2.69
Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology (2012) 2.68
Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63
Short sleep duration in infancy and risk of childhood overweight. Arch Pediatr Adolesc Med (2008) 2.61
Decreasing prevalence of obesity among young children in Massachusetts from 2004 to 2008. Pediatrics (2012) 2.58
Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 2.57
Displaying the relatedness among isolates of bacterial species -- the eBURST approach. FEMS Microbiol Lett (2004) 2.56
Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics (2002) 2.54
Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens (2008) 2.50
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Assigning strains to bacterial species via the internet. BMC Biol (2009) 2.49
Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health (2006) 2.47
Neutral microepidemic evolution of bacterial pathogens. Proc Natl Acad Sci U S A (2005) 2.42
Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res (2011) 2.41
Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med (2014) 2.41
Health care use and decision making among lower-income families in high-deductible health plans. Arch Intern Med (2010) 2.37
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis (2009) 2.36
Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol (2007) 2.36
Trends in overweight from 1980 through 2001 among preschool-aged children enrolled in a health maintenance organization. Obesity (Silver Spring) (2006) 2.31
Weight status in the first 6 months of life and obesity at 3 years of age. Pediatrics (2009) 2.30
Multivariate scan statistics for disease surveillance. Stat Med (2007) 2.27
Real-time influenza forecasts during the 2012-2013 season. Nat Commun (2013) 2.26
Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti. MBio (2013) 2.24
HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J Immunol (2005) 2.24
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol (2006) 2.22
Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med (2011) 2.22
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4. Appl Environ Microbiol (2003) 2.19
Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med (2012) 2.17
Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med (2002) 2.15
Descriptive epidemiology and attributable morbidity of ventilator-associated events. Infect Control Hosp Epidemiol (2014) 2.15
Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program. J Urban Health (2003) 2.15
Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J (2009) 2.12
Randomized controlled trial to improve primary care to prevent and manage childhood obesity: the High Five for Kids study. Arch Pediatr Adolesc Med (2011) 2.12
Crossing growth percentiles in infancy and risk of obesity in childhood. Arch Pediatr Adolesc Med (2011) 2.11
Association of consumption of fried food away from home with body mass index and diet quality in older children and adolescents. Pediatrics (2005) 2.09
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08